KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LiveRamp Holdings (RAMP) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for LiveRamp Holdings (RAMP) over the last 17 years, with Sep 2025 value amounting to $369.4 million.

  • LiveRamp Holdings' Cash & Equivalents rose 9.00% to $369.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.4 million, marking a year-over-year increase of 9.00%. This contributed to the annual value of $413.3 million for FY2025, which is 22.70% up from last year.
  • Per LiveRamp Holdings' latest filing, its Cash & Equivalents stood at $369.4 million for Q3 2025, which was up 1.60% from $363.6 million recorded in Q2 2025.
  • LiveRamp Holdings' 5-year Cash & Equivalents high stood at $600.2 million for Q1 2022, and its period low was $310.4 million during Q2 2024.
  • Its 3-year average for Cash & Equivalents is $403.2 million, with a median of $376.8 million in 2024.
  • Per our database at Business Quant, LiveRamp Holdings' Cash & Equivalents slumped by 34.07% in 2024 and then increased by 22.70% in 2025.
  • Quarterly analysis of 5 years shows LiveRamp Holdings' Cash & Equivalents stood at $553.0 million in 2021, then declined by 17.98% to $453.5 million in 2022, then rose by 10.02% to $498.9 million in 2023, then decreased by 24.49% to $376.8 million in 2024, then rose by 9.00% to $369.4 million in 2025.
  • Its Cash & Equivalents was $369.4 million in Q3 2025, compared to $363.6 million in Q2 2025 and $413.3 million in Q1 2025.